Literature DB >> 29233641

Biphasic hierarchical extracellular matrix scaffold for osteochondral defect regeneration.

X Lin1, J Chen1, P Qiu1, Q Zhang1, S Wang1, M Su1, Y Chen1, K Jin2, A Qin3, S Fan4, P Chen5, X Zhao6.   

Abstract

OBJECTIVE: To investigate the effect of decellularized osteochondral extracellular matrix (ECM) scaffold for osteochondral defect regeneration.
DESIGN: We compared the histological features and microstructure of degenerated cartilage to normal articular cartilage. We also generated and evaluated osteochondral ECM scaffolds through decellularization technology. Then scaffolds were implanted to osteochondral defect in rabbit model. After 12 weeks surgery, regeneration tissues were analyzed by histology, immunohistochemistry evaluation. And possible mechanisms of angiogenesis and cell migration were explored.
RESULTS: We demonstrated decreased cell numbers, formation of fibrous cartilage, lost microstructure and worse permeability in degenerated cartilage compared to normal cartilage. We also generated an osteochondral ECM scaffold with a hierarchical structure that exhibited low immunogenicity, high bioactivity, and well biocompatibility. We found that the ECM scaffold promoted tissue regeneration in osteochondral defects, which was dependent on the scaffold constituents and stratified three-dimensional microstructure as well as on its ability to inhibit angiogenesis and stimulate cell migration.
CONCLUSIONS: Our findings demonstrated that the biphasic hierarchical ECM scaffold represents a novel and effective biomaterial that can be used in the treatment of osteochondral defect.
Copyright © 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage; Extracellular matrix; Osteoarthritis; Osteochondral defect; Subchondral bone

Mesh:

Year:  2017        PMID: 29233641     DOI: 10.1016/j.joca.2017.12.001

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

1.  Chemical Immobilization of Carboxymethyl Chitosan on Polycaprolactone Nanofibers as Osteochondral Scaffolds.

Authors:  Anita Kabirkoohian; Hadi Bakhshi; Shiva Irani; Fereshteh Sharifi
Journal:  Appl Biochem Biotechnol       Date:  2022-04-30       Impact factor: 2.926

2.  Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration.

Authors:  Pengfei Chen; Lin Zheng; Yiyun Wang; Min Tao; Ziang Xie; Chen Xia; Chenhui Gu; Jiaxin Chen; Pengcheng Qiu; Sheng Mei; Lei Ning; Yiling Shi; Chen Fang; Shunwu Fan; Xianfeng Lin
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

3.  Evaluation of bone allograft processing methods: Impact on decellularization efficacy, biocompatibility and mesenchymal stem cell functionality.

Authors:  Alexander Rasch; Hendrik Naujokat; Fanlu Wang; Andreas Seekamp; Sabine Fuchs; Tim Klüter
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

Review 4.  Reconstructing Bone with Natural Bone Graft: A Review of In Vivo Studies in Bone Defect Animal Model.

Authors:  Mengying Liu; Yonggang Lv
Journal:  Nanomaterials (Basel)       Date:  2018-12-03       Impact factor: 5.076

Review 5.  Osteochondral tissue engineering: Perspectives for clinical application and preclinical development.

Authors:  Chengchong Ai; Yee Han Dave Lee; Xuan Hao Tan; Si Heng Sharon Tan; James Hoi Po Hui; James Cho-Hong Goh
Journal:  J Orthop Translat       Date:  2021-10-11       Impact factor: 5.191

Review 6.  3D Printing for Bone-Cartilage Interface Regeneration.

Authors:  Jialian Xu; Jindou Ji; Juyang Jiao; Liangjun Zheng; Qimin Hong; Haozheng Tang; Shutao Zhang; Xinhua Qu; Bing Yue
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

Review 7.  Material-Assisted Strategies for Osteochondral Defect Repair.

Authors:  Constance Lesage; Marianne Lafont; Pierre Guihard; Pierre Weiss; Jérôme Guicheux; Vianney Delplace
Journal:  Adv Sci (Weinh)       Date:  2022-03-24       Impact factor: 17.521

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.